| Application no. and date | 05731600.2 (espacenet) (Federated) (European Patent Register), 20050314 | | Patent/reg. no. and date | DK/EP 1725233, 20110105 | | Publication date | 20061129 | | Priority no. and date | US 553578 P, 20040315 | | EP pub. no. and date |
EP 1725233 20061129 | | Effective date | | | Applicant/owner | Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome
Chuo-ku, Osaka-shi
Osaka 541-8524
, JP,
Sunesis Pharmaceuticals, Inc., 395 Oyster Point Blvd., Suite 400
South San Francisco, CA 94080, US | | Applicant ref. no. | P81008647DK0E | | Inventor | HIGAKI, Masaru, 5-51,Ebie 1-chome,Fukushima-ku
Osaka-shi, Osaka, JP,
NAKAO Satoshi, 5-51, Ebie 1-chome, Fukushima-ku
Osaka-shi, Osaka, 553-0001, JP | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 38/18 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | Farmaceutisk sammensætning omfattende SNS-595 og anvendelse deraf | | Int. application no. | US2005008346 | | Int. publication no. | WO2005089757 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
